BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 35037605)

  • 1. A Single-Center Study of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Recurrence in Recipients of Liver Transplant for Treatment of Nonalcoholic Steatohepatitis Cirrhosis.
    Matsuoka L; Chotai PN; Slaughter J; Campbell K; Kerr A; Hamel S; Garza C; Alexopoulos SP; Scanga A
    Exp Clin Transplant; 2022 Feb; 20(2):150-156. PubMed ID: 35037605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
    Piazza NA; Singal AK
    Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Steatohepatitis Is the Most Rapidly Growing Indication for Liver Transplantation in Iranian Patients.
    Eshraghian A; Nikeghbalian S; Dehghani M; Shamsaeefar A; Kazemi K; Nikoopour H; Eghlimi H; Gholami S; Salahi H; Malek-Hosseini SA
    Exp Clin Transplant; 2022 May; 20(5):487-494. PubMed ID: 31580238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis.
    Eshraghian A; Nikeghbalian S; Kazemi K; Shamsaeefar A; Geramizadeh B; Malek-Hosseini SA
    HPB (Oxford); 2020 Apr; 22(4):521-528. PubMed ID: 31431413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
    Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
    Singal AK; Hasanin M; Kaif M; Wiesner R; Kuo YF
    Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges.
    Samji NS; Verma R; Keri KC; Singal AK; Ahmed A; Rinella M; Bernstein D; Abdelmalek MF; Satapathy SK
    Dig Dis Sci; 2019 Dec; 64(12):3413-3430. PubMed ID: 31312990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation.
    Tokodai K; Karadagi A; Kjaernet F; Romano A; Ericzon BG; Nowak G
    Scand J Gastroenterol; 2019 Feb; 54(2):233-239. PubMed ID: 30999770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Genetic Risk Factors of Recurrent Nonalcoholic Fatty Liver Disease After Liver Transplantation.
    Satapathy SK; Tran QT; Kovalic AJ; Bontha SV; Jiang Y; Kedia S; Karri S; Mupparaju V; Podila PSB; Verma R; Maluf D; Mas V; Nair S; Eason JD; Bridges D; Kleiner DE
    Clin Transl Gastroenterol; 2021 Feb; 12(2):e00302. PubMed ID: 33555168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis.
    Agbim U; Jiang Y; Kedia SK; Singal AK; Ahmed A; Bhamidimarri KR; Bernstein DE; Harrison SA; Younossi ZM; Satapathy SK
    Liver Transpl; 2019 Jan; 25(1):68-78. PubMed ID: 30091296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Noninvasive Fibrosis Scores in Predicting the Presence of Fibrosis in Patients after Liver Transplantation.
    Kabbany MN; Conjeevaram Selvakumar PK; Guirguis J; Rivas J; Akras Z; Lopez R; Hanouneh I; Eghtesad B; Alkhouri N
    Exp Clin Transplant; 2018 Oct; 16(5):562-567. PubMed ID: 28952917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing prevalence of nonalcoholic steatohepatitis as an indication for liver transplantation.
    Quillin RC; Wilson GC; Sutton JM; Hanseman DJ; Paterno F; Cuffy MC; Paquette IM; Diwan TS; Woodle ES; Abbott DE; Shah SA
    Surgery; 2014 Oct; 156(4):1049-56. PubMed ID: 25239365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis.
    Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA
    Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis.
    Altshuler PJ; Dang H; Frank AM; Shah AP; Glorioso J; Zhan T; Rios Diaz A; Shaheen O; Ramirez CB; Maley WR; Bodzin AS
    Liver Transpl; 2022 Apr; 28(4):623-635. PubMed ID: 34564931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Recurrent and De Novo NAFLD/NASH After Liver Transplantation.
    Germani G; Laryea M; Rubbia-Brandt L; Egawa H; Burra P; OʼGrady J; Watt KD
    Transplantation; 2019 Jan; 103(1):57-67. PubMed ID: 30335694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis.
    Bhati C; Idowu MO; Sanyal AJ; Rivera M; Driscoll C; Stravitz RT; Kohli DR; Matherly S; Puri P; Gilles H; Cotterell A; Levy M; Sterling RK; Luketic VA; Lee H; Sharma A; Siddiqui MS
    Transplantation; 2017 Aug; 101(8):1867-1874. PubMed ID: 28296807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of liver transplantation in patients with prior bariatric surgery.
    Safwan M; Collins KM; Abouljoud MS; Salgia R
    Liver Transpl; 2017 Nov; 23(11):1415-1421. PubMed ID: 28752920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant.
    Chandrakumaran A; Siddiqui MS
    Gastroenterol Clin North Am; 2020 Mar; 49(1):165-178. PubMed ID: 32033762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of extended criteria donors in liver transplantation for nonalcoholic steatohepatitis.
    Dimou FM; Mehta HB; Adhikari D; Harland RC; Riall TS; Kuo YF
    Surgery; 2016 Dec; 160(6):1533-1543. PubMed ID: 27554622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.